374 related articles for article (PubMed ID: 27002129)
1. AB5 Preassembly Is Not Required for Shiga Toxin Activity.
Pellino CA; Karve SS; Pradhan S; Weiss AA
J Bacteriol; 2016 Jun; 198(11):1621-1630. PubMed ID: 27002129
[TBL] [Abstract][Full Text] [Related]
2. The A1 Subunit of Shiga Toxin 2 Has Higher Affinity for Ribosomes and Higher Catalytic Activity than the A1 Subunit of Shiga Toxin 1.
Basu D; Li XP; Kahn JN; May KL; Kahn PC; Tumer NE
Infect Immun; 2016 Jan; 84(1):149-61. PubMed ID: 26483409
[TBL] [Abstract][Full Text] [Related]
3. Switching Shiga Toxin (Stx) Type from Stx2d to Stx2a but Not Stx2c Alters Virulence of Stx-Producing
McNichol BA; Bova RA; Torres K; Preston LN; Melton-Celsa AR
Toxins (Basel); 2021 Jan; 13(1):. PubMed ID: 33467588
[TBL] [Abstract][Full Text] [Related]
4. Development and characterization of recombinant antibody fragments that recognize and neutralize in vitro Stx2 toxin from Shiga toxin-producing Escherichia coli.
Luz D; Chen G; Maranhão AQ; Rocha LB; Sidhu S; Piazza RM
PLoS One; 2015; 10(3):e0120481. PubMed ID: 25790467
[TBL] [Abstract][Full Text] [Related]
5. Do the A subunits contribute to the differences in the toxicity of Shiga toxin 1 and Shiga toxin 2?
Basu D; Tumer NE
Toxins (Basel); 2015 Apr; 7(5):1467-85. PubMed ID: 25938272
[TBL] [Abstract][Full Text] [Related]
6. Comparisons of native Shiga toxins (Stxs) type 1 and 2 with chimeric toxins indicate that the source of the binding subunit dictates degree of toxicity.
Russo LM; Melton-Celsa AR; Smith MJ; O'Brien AD
PLoS One; 2014; 9(3):e93463. PubMed ID: 24671194
[TBL] [Abstract][Full Text] [Related]
7. Shiga Toxin Type 1a (Stx1a) Reduces the Toxicity of the More Potent Stx2a
Petro CD; Trojnar E; Sinclair J; Liu ZM; Smith M; O'Brien AD; Melton-Celsa A
Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30670557
[TBL] [Abstract][Full Text] [Related]
8. Reduced Toxicity of Shiga Toxin (Stx) Type 2c in Mice Compared to Stx2d Is Associated with Instability of Stx2c Holotoxin.
Bunger JC; Melton-Celsa AR; Maynard EL; O'Brien AD
Toxins (Basel); 2015 Jun; 7(6):2306-20. PubMed ID: 26110507
[TBL] [Abstract][Full Text] [Related]
9. Bimodal Response to Shiga Toxin 2 Subtypes Results from Relatively Weak Binding to the Target Cell.
Cherubin P; Fidler D; Quiñones B; Teter K
Infect Immun; 2019 Dec; 87(12):. PubMed ID: 31527121
[TBL] [Abstract][Full Text] [Related]
10. Combining Mass Spectrometry, Surface Acoustic Wave Interaction Analysis, and Cell Viability Assays for Characterization of Shiga Toxin Subtypes of Pathogenic Escherichia coli Bacteria.
Steil D; Pohlentz G; Legros N; Mormann M; Mellmann A; Karch H; Müthing J
Anal Chem; 2018 Aug; 90(15):8989-8997. PubMed ID: 29939014
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic Antibodies Against Shiga Toxins: Trends and Perspectives.
Henrique IM; Sacerdoti F; Ferreira RL; Henrique C; Amaral MM; Piazza RMF; Luz D
Front Cell Infect Microbiol; 2022; 12():825856. PubMed ID: 35223548
[TBL] [Abstract][Full Text] [Related]
12. Human intestinal tissue and cultured colonic cells contain globotriaosylceramide synthase mRNA and the alternate Shiga toxin receptor globotetraosylceramide.
Zumbrun SD; Hanson L; Sinclair JF; Freedy J; Melton-Celsa AR; Rodriguez-Canales J; Hanson JC; O'Brien AD
Infect Immun; 2010 Nov; 78(11):4488-99. PubMed ID: 20732996
[TBL] [Abstract][Full Text] [Related]
13. Glycolipid binding preferences of Shiga toxin variants.
Karve SS; Weiss AA
PLoS One; 2014; 9(7):e101173. PubMed ID: 24983355
[TBL] [Abstract][Full Text] [Related]
14. Escherichia coli Shiga toxin.
Nakao H; Takeda T
J Nat Toxins; 2000 Aug; 9(3):299-313. PubMed ID: 10994531
[TBL] [Abstract][Full Text] [Related]
15. The effect of probiotics and organic acids on Shiga-toxin 2 gene expression in enterohemorrhagic Escherichia coli O157:H7.
Carey CM; Kostrzynska M; Ojha S; Thompson S
J Microbiol Methods; 2008 May; 73(2):125-32. PubMed ID: 18328583
[TBL] [Abstract][Full Text] [Related]
16. Effect of antibiotics on cellular stress generated in Shiga toxin-producing Escherichia coli O157:H7 and non-O157 biofilms.
Angel Villegas N; Baronetti J; Albesa I; Etcheverría A; Becerra MC; Padola NL; Paraje MG
Toxicol In Vitro; 2015 Oct; 29(7):1692-700. PubMed ID: 26130220
[TBL] [Abstract][Full Text] [Related]
17. Expression of Shiga toxin 2 (Stx2) in highly virulent Stx-producing Escherichia coli (STEC) carrying different anti-terminator (q) genes.
Olavesen KK; Lindstedt BA; Løbersli I; Brandal LT
Microb Pathog; 2016 Aug; 97():1-8. PubMed ID: 27208749
[TBL] [Abstract][Full Text] [Related]
18. The Shiga toxin genotype rather than the amount of Shiga toxin or the cytotoxicity of Shiga toxin in vitro correlates with the appearance of the hemolytic uremic syndrome.
Orth D; Grif K; Khan AB; Naim A; Dierich MP; Würzner R
Diagn Microbiol Infect Dis; 2007 Nov; 59(3):235-42. PubMed ID: 17931818
[TBL] [Abstract][Full Text] [Related]
19. A Conserved Structural Motif Mediates Retrograde Trafficking of Shiga Toxin Types 1 and 2.
Selyunin AS; Mukhopadhyay S
Traffic; 2015 Dec; 16(12):1270-87. PubMed ID: 26420131
[TBL] [Abstract][Full Text] [Related]
20. Peptides derived from phage display libraries as potential neutralizers of Shiga toxin-induced cytotoxicity in vitro and in vivo.
Bernedo-Navarro RA; Miyachiro MM; da Silva MJ; Reis CF; Conceição RA; Gatti MS; Yano T
J Appl Microbiol; 2014 May; 116(5):1322-33. PubMed ID: 24447276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
